Healthcare Startup SigTuple Raises $19 Million In Series B Round Funding

(L-R) SigTuple founders Apurv Anand, Tathagato Rai Dastidar and Rohit Kumar Pandey.

Bengaluru-based healthcare startup SigTuple has raised $19 million (₹130 crore) in the Series B round of funding. Founded 2015 by former American Express employees Rohit Kumar Pandey, Tathagato Rai Dastidar and Apurv Anand, the company has raised $6.5 million from different investors so far.

The Series B round was led by IDG Ventures and Accel Partners along with pi Ventures, Endiya Partners, VH Capital, Axilor Ventures and Flipkart’s executive chairman Binny Bansal. SigTuple has also raised venture debt from Trifecta Capital in this round.

The company has been working on a low-cost system for examining blood, urine and semen samples using artificial intelligence to recognise microscopic images. Using SigTuple’s own software, their machine can now recognise these samples to differentiate between normal and abnormal cells.

Subscribe to our Newsletter

Join our editors every weekday evening as they steer you through the most significant news of the day, introduce you to fresh perspectives, and provide unexpected moments of joy
Your newsletter subscriptions are subject to AIM Privacy Policy and Terms and Conditions.

Pandey the chief executive at SigTuple told a financial newspaper, “The major chunk [of money from this investment] will go into setting up a manufacturing pipeline so that we can put more devices in the market. We have applied for US FDA and CE certification. Once we go through the stage, it will require more clinical trials for different market deployments. We will be investing money in this. We need to have a sales and support teams as well.”

SigTuple has been using AI to develop hardware and software products that would digitise pathology results from hospitals. Now, with the new funding in hand, SigTuple plans to use it to further advance in research and development of their products. They also want to enhance their assembly, distribution and conduct more clinical trials.

“There is a tremendous opportunity to make healthcare accessible, affordable and accurate. Year after year our confidence to transform healthcare delivery has increased. We are excited about the future as we are gearing up to take our solutions and services to the larger population,” added Pandey.

Prajakta Hebbar
Prajakta is a Writer/Editor/Social Media diva. Lover of all that is 'quaint', her favourite things include dogs, Starbucks, butter popcorn, Jane Austen novels and neo-noir films. She has previously worked for HuffPost, CNN IBN, The Indian Express and Bose.

Download our Mobile App


AI Hackathons, Coding & Learning

Host Hackathons & Recruit Great Data Talent!

AIM Research

Pioneering advanced AI market research

Request Customised Insights & Surveys for the AI Industry

The Gold Standard for Recognizing Excellence in Data Science and Tech Workplaces

With Best Firm Certification, you can effortlessly delve into the minds of your employees, unveil invaluable perspectives, and gain distinguished acclaim for fostering an exceptional company culture.

AIM Leaders Council

World’s Biggest Community Exclusively For Senior Executives In Data Science And Analytics.

3 Ways to Join our Community

Telegram group

Discover special offers, top stories, upcoming events, and more.

Discord Server

Stay Connected with a larger ecosystem of data science and ML Professionals

Subscribe to our Daily newsletter

Get our daily awesome stories & videos in your inbox

Subscribe to Our Newsletter

The Belamy, our weekly Newsletter is a rage. Just enter your email below.